Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2005
11/23/2005EP1596656A2 Pyrazoles and methods of making and using the same
11/23/2005EP0811007B1 Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
11/23/2005CN1701072A Heterocyclic substituted piperazines for the treatment of schizophrenia
11/23/2005CN1701069A 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases
11/23/2005CN1699363A Vla-4 inhibitors
11/23/2005CN1699350A Processes and intermediates for preparing anti-cancer compounds
11/23/2005CN1228337C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
11/22/2005US6967216 Neuropeptide Y receptor modulators; treating eating disorders
11/22/2005US6967214 Inhibitors of IMPDH enzyme
11/22/2005US6967212 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
11/22/2005US6967208 Anticoagulants; cardiovascular disorders
11/17/2005WO2005108391A1 Amides as bace inhibitors
11/17/2005WO2005108389A1 Indole derivatives having piperidine rings
11/17/2005WO2005108384A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands
11/17/2005WO2005108382A1 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/17/2005WO2005108373A1 Novel beta agonists, method for producing the same and their use as drugs
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005108359A1 Novel compounds of proline and morpholine derivatives
11/17/2005WO2005108358A2 Pyrrolidine derivatives useful as bace inhibitors
11/17/2005WO2005107758A1 4-phenylamino-quinazolin-6-yl-amides
11/17/2005WO2005058834A3 Quinolines useful in treating cardiovascular disease
11/17/2005WO2005051906A3 Heterocyclic inhibitors of mek and methods of use thereof
11/17/2005WO2005034857A8 Methods and compositions comprising diamines as new anti-tubercular therapeutics
11/17/2005WO2004082602A3 Carboxamide spirohydantoin cgrp receptor antagonists
11/17/2005US20050256310 Therapeutic compounds
11/17/2005US20050256199 2-Amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
11/17/2005US20050256185 Spiro and dispiro 1,2,4-trioxolane antimalarials
11/17/2005US20050256180 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics
11/17/2005US20050256170 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders
11/17/2005US20050256167 Preparation and use of imidazole derivatives for treatment of obesity
11/17/2005US20050256166 Nitrogen-containing compounds
11/17/2005US20050256159 1,4-disubstituted piperidine derivatives and their use as 11,betahsd1 inhibitors
11/17/2005US20050256158 PGD2 receptor antagonists for the treatment of inflammatory diseases
11/17/2005US20050256145 Pyrimidine derivatives for the treatment of abnormal cell growth
11/17/2005US20050256136 1-[2-(3-Ethyl-ureido)-3H-benzoimidazol-5-yl]-1H-imiazole-4-carboxylic acid methyl ester; bacteriostatic antibiotic; decrease antibiotic resistance of bacterial organisms; new class of compounds for bacterial infections
11/17/2005US20050256130 Substituted piperazines
11/17/2005US20050256123 Heterocyclic inhibitors of MEK and methods of use thereof
11/17/2005US20050256121 Substituted 2,5-heterocyclic derivatives
11/17/2005US20050256120 Heterocyclo-substituted imidazoles for the treatment of inflammation
11/17/2005US20050256118 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
11/17/2005US20050256117 Ophthalmic compositions for treating ocular hypertension
11/17/2005US20050256113 Anti-cytokine heterocyclic compounds
11/17/2005US20050256110 Cyanopyrroles
11/17/2005US20050256107 New substituted thiophene carboxamides, process for their preparation and their use as medicaments
11/17/2005US20050256104 Protease inhibitors
11/17/2005US20050256103 Indole derivative having piperidine ring
11/17/2005US20050256100 Protease inhibitors
11/17/2005US20050256099 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
11/17/2005US20050256098 CGRP receptor antagonists
11/17/2005US20050256078 Hepatitis C; toxicity, side effects reduction; improved pharmacological/pharmacokinetics properties; novel intermediates; increased cellular accumulation and retention of a drug compound, to improve their therapeutic and diagnostic value, comprising linking the compound to one or more phosphonate groups
11/17/2005US20050256003 Novel herbicides
11/17/2005US20050256000 Quinoxalin-2-one derivatives, compositions which protect useful plants and comprise these derivatives, and processes for their preparation and their use
11/17/2005DE102004018953A1 4-Halogenalkylpyridin-3-sulfonsäureamide, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel 4-haloalkylpyridine-3-sulfonamides, process for their preparation, compositions containing them and their use as pesticides
11/17/2005CA2565843A1 Novel compounds of proline and morpholine derivatives
11/17/2005CA2564980A1 Novel beta agonists, method for producing the same and their use as drugs
11/17/2005CA2564264A1 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/16/2005EP1594867A2 Phenylacetamides and their use as glucokinase modulators
11/16/2005EP1594865A2 Antibacterial agents
11/16/2005EP1594863A1 Tri(cyclo) substituted amide glucokinase activator compounds
11/16/2005EP1594853A1 Method for the production of bicyclic aromatic amino acids and intermediate products thereof
11/16/2005EP1594852A1 Oxazolidinone derivatives as antimicrobials
11/16/2005EP1594847A2 Substituted azole derivatives as therapeutic agents
11/16/2005EP1594841A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
11/16/2005EP1594840A1 Piperidine-benzenesulfonamide derivatives
11/16/2005EP1594501A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/16/2005EP1594495A1 Oxazolidinone derivates n-substituted by a tricyclic ring, for use as antibacterial agents
11/16/2005EP1594494A1 Oxazolidinone derivatives n-substituted by a bicyclic ring, for use as antibacterial agents
11/16/2005EP1492795B1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
11/16/2005EP1370557B1 Benzimidazole anti-inflammatory compounds
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1326850B1 A process for the preparation of bis-benzazolyl compounds
11/16/2005EP1317442B1 Quinolinone derivatives as tyrosine kinase inhibitors
11/16/2005EP1222182B1 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
11/16/2005EP1218374B1 Pharmaceutically active sulfonamide derivatives
11/16/2005EP0979227B1 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
11/16/2005CN1697835A Pyridyl substituted heterocycles useful for treating or preventing HCV infection
11/16/2005CN1696129A Novel process for the synthesis of carboxylic acid phenylamide
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/16/2005CN1227238C Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidiones as antibacterials
11/16/2005CN1227236C Substituted imidazole neuropeptide YY5 receptor antagonists
11/16/2005CN1227231C Ether and amide compounds as medicine for treating glycuresis and preparing process thereof
11/16/2005CN1227229C Ethylene derivatives and pest controlling agents containing same
11/15/2005US6965036 Intermediates for guanidine mimics as factor Xa inhibitors
11/15/2005US6965034 Deoxygenation of epothilone A or B, to form desoxyepothilone used as nontoxic anticarcinogenic agents
11/15/2005US6965032 Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates and their preparation and use
11/15/2005US6964983 Compounds that modulate PPAR activity and methods for their preparation
11/15/2005US6964975 Isoxazole and thiazole compounds and use thereof as medicine
11/15/2005US6964973 Nonsteroidal agonists and antagonists
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/15/2005US6964966 Such as 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-amino-3-methyl-1 -piperidinyl)-4-oxo-quinoline-3-carboxylic acid for treatment of systemic or topical infections
11/15/2005CA2330351C New linear or cyclical ureas, their preparation process and the pharmaceutical compositions which contain them
11/15/2005CA2207627C 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
11/15/2005CA2179640C Watersoluble azole antifungals
11/15/2005CA2167183C Process for making hiv protease inhibitors
11/10/2005WO2005105817A2 Coupling process for generating reactive boron­ containing derivatives of n-substituted pyrrole-2­ carbonitriles to produce biaryls
11/10/2005WO2005105792A1 Process for preparing optically pure zolmitriptan
11/10/2005WO2005105791A1 Indolyl derivatives as liver-x-receptor modulators
11/10/2005WO2005105790A1 4- 2- (cycloalkylamino) pyrimidin-4-yl ! - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases
11/10/2005WO2005105788A1 Indole derivatives and use thereof as kinase inhibitors
11/10/2005WO2005105780A2 Compositions useful as inhibitors of rock and other protein kinases